Publication & Citation Trends
Publications
624 total
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Cited by 2,676
OpenAlex
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma PDF
Cited by 2,629
OpenAlex
Research Topics
Retinoids in leukemia and cellular processes
(102)
Cancer Immunotherapy and Biomarkers
(80)
Acute Myeloid Leukemia Research
(77)
Melanoma and MAPK Pathways
(73)
PI3K/AKT/mTOR signaling in cancer
(56)
Affiliations
Lyon 1 Université
Northwestern University
Ontario Institute for Cancer Research
University of North Carolina at Chapel Hill
Western University
External Profiles
Continue on JournalsHub
Put what you just read into practice with these free tools.